Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. more
Time Frame | RXST | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.96% | -2.12% | 0.77% |
1-Month Return | -21.16% | -2.54% | 2.65% |
3-Month Return | -18.51% | -6.28% | 12.3% |
6-Month Return | -26.5% | -1.36% | 13.48% |
1-Year Return | 28.58% | 9.29% | 33.47% |
3-Year Return | 291.92% | 10.05% | 32.22% |
5-Year Return | 169.69% | 43.69% | 92.85% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 2.24M | 14.68M | 22.59M | 49.01M | 89.08M | [{"date":"2019-12-31","value":2.52,"profit":true},{"date":"2020-12-31","value":16.48,"profit":true},{"date":"2021-12-31","value":25.36,"profit":true},{"date":"2022-12-31","value":55.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 4.06M | 12.97M | 18.08M | 27.68M | 35.31M | [{"date":"2019-12-31","value":11.5,"profit":true},{"date":"2020-12-31","value":36.74,"profit":true},{"date":"2021-12-31","value":51.19,"profit":true},{"date":"2022-12-31","value":78.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (1.82M) | 1.71M | 4.52M | 21.33M | 53.77M | [{"date":"2019-12-31","value":-3.38,"profit":false},{"date":"2020-12-31","value":3.17,"profit":true},{"date":"2021-12-31","value":8.4,"profit":true},{"date":"2022-12-31","value":39.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | (81.17%) | 11.62% | 19.99% | 43.52% | 60.36% | [{"date":"2019-12-31","value":-134.48,"profit":false},{"date":"2020-12-31","value":19.25,"profit":true},{"date":"2021-12-31","value":33.12,"profit":true},{"date":"2022-12-31","value":72.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 44.77M | 37.11M | 57.30M | 84.65M | 103.85M | [{"date":"2019-12-31","value":43.11,"profit":true},{"date":"2020-12-31","value":35.73,"profit":true},{"date":"2021-12-31","value":55.18,"profit":true},{"date":"2022-12-31","value":81.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (46.07M) | (35.41M) | (52.79M) | (63.32M) | (50.09M) | [{"date":"2019-12-31","value":-4607000000,"profit":false},{"date":"2020-12-31","value":-3540500000,"profit":false},{"date":"2021-12-31","value":-5278700000,"profit":false},{"date":"2022-12-31","value":-6331800000,"profit":false},{"date":"2023-12-31","value":-5008500000,"profit":false}] |
Total Non-Operating Income/Expense | 174.59M | 63.07M | 479.00K | (6.86M) | 4.76M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":36.12,"profit":true},{"date":"2021-12-31","value":0.27,"profit":true},{"date":"2022-12-31","value":-3.93,"profit":false},{"date":"2023-12-31","value":2.73,"profit":true}] |
Pre-Tax Income | 126.24M | 27.63M | (48.68M) | (66.75M) | (48.59M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.89,"profit":true},{"date":"2021-12-31","value":-38.56,"profit":false},{"date":"2022-12-31","value":-52.87,"profit":false},{"date":"2023-12-31","value":-38.49,"profit":false}] |
Income Taxes | 24.00K | 57.00K | 8.00K | 9.00K | 20.00K | [{"date":"2019-12-31","value":42.11,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":14.04,"profit":true},{"date":"2022-12-31","value":15.79,"profit":true},{"date":"2023-12-31","value":35.09,"profit":true}] |
Income After Taxes | 126.22M | 27.57M | (48.69M) | (66.76M) | (48.61M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.85,"profit":true},{"date":"2021-12-31","value":-38.57,"profit":false},{"date":"2022-12-31","value":-52.89,"profit":false},{"date":"2023-12-31","value":-38.51,"profit":false}] |
Income From Continuous Operations | 126.22M | 27.57M | (48.69M) | (66.76M) | (48.61M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.85,"profit":true},{"date":"2021-12-31","value":-38.57,"profit":false},{"date":"2022-12-31","value":-52.89,"profit":false},{"date":"2023-12-31","value":-38.51,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 126.22M | 27.57M | (48.69M) | (66.76M) | (48.61M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.85,"profit":true},{"date":"2021-12-31","value":-38.57,"profit":false},{"date":"2022-12-31","value":-52.89,"profit":false},{"date":"2023-12-31","value":-38.51,"profit":false}] |
EPS (Diluted) | - | (1.70) | (2.13) | (2.42) | (1.38) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-170.28,"profit":false},{"date":"2021-12-31","value":-213,"profit":false},{"date":"2022-12-31","value":-242,"profit":false},{"date":"2023-12-31","value":-138,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
RXST | |
---|---|
Cash Ratio | 10.47 |
Current Ratio | 12.67 |
Quick Ratio | 11.71 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RXST | |
---|---|
ROA (LTM) | -9.92% |
ROE (LTM) | -13.99% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RXST | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.11 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.89 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RXST | |
---|---|
Trailing PE | NM |
Forward PE | 80.00 |
P/S (TTM) | 13.56 |
P/B | 6.27 |
Price/FCF | NM |
EV/R | 11.80 |
EV/Ebitda | NM |
Rxsight Inc (RXST) share price today is $43.15
Yes, Indians can buy shares of Rxsight Inc (RXST) on Vested. To buy Rxsight Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RXST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Rxsight Inc (RXST) via the Vested app. You can start investing in Rxsight Inc (RXST) with a minimum investment of $1.
You can invest in shares of Rxsight Inc (RXST) via Vested in three simple steps:
The 52-week high price of Rxsight Inc (RXST) is $66.54. The 52-week low price of Rxsight Inc (RXST) is $33.95.
The price-to-earnings (P/E) ratio of Rxsight Inc (RXST) is
The price-to-book (P/B) ratio of Rxsight Inc (RXST) is 6.27
The dividend yield of Rxsight Inc (RXST) is 0.00%
The market capitalization of Rxsight Inc (RXST) is $1.74B
The stock symbol (or ticker) of Rxsight Inc is RXST